Summary
Vertex Pharmaceuticals Inc. (VRTX) filed an 8-K on February 5, 2014, announcing an amendment to its Amended and Restated By-laws. This change, effective February 4, 2014, modifies the voting standard for director elections. Specifically, uncontested director elections will now require a majority vote, a shift from the previous plurality standard that applied to all elections. Contested director elections will continue to operate under a plurality vote standard.
Key Highlights
- 1Vertex Pharmaceuticals amended its By-laws on February 4, 2014.
- 2The amendment pertains to Article I, Section 8 of the Amended and Restated By-laws.
- 3A majority vote standard is now required for uncontested director elections.
- 4A plurality vote standard remains in place for contested director elections.
- 5Previously, a plurality vote standard applied to all director elections.
- 6The change aims to enhance shareholder governance by requiring a higher threshold for approval in uncontested situations.
- 7The full Amended and Restated By-laws are filed as an exhibit to the 8-K.